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E2F transcription factors play a critical role in cell cycle progression through the regulation of genes
required for G1/S transition. They are also thought to be important for growth arrest; however, their potential
role in the cell differentiation process has not been previously examined. Here, we demonstrate that E2F4 is
highly upregulated following the neuronal differentiation of PC12 cells with nerve growth factor (NGF), while
E2F1, E2F3, and E2F5 are downregulated. Immunoprecipitation and subcellular fractionation studies dem-
onstrated that both the nuclear localization of E2F4 and its association with the Rb family member p130
increased following neuronal differentiation. The forced expression of E2F4 markedly enhanced the rate of
PC12 cell differentiation induced by NGF and also greatly lowered the rate at which cells lost their neuronal
phenotype following NGF removal. Importantly, this effect occurred in the absence of any significant change
in the growth regulation of PC12 cells by NGF. Further, the downregulation of E2F4 expression with antisense
oligodeoxynucleotides inhibited NGF-induced neurite outgrowth, indicating an important role for this factor
during PC12 cell differentiation. Finally, E2F4 expression was found to increase dramatically in the developing
rat cerebral cortex and cerebellum, as neuroblasts became postmitotic and initiated terminal differentiation.
These findings demonstrate that, in addition to its effects on cell proliferation, E2F4 actively promotes the
neuronal differentiation of PC12 cells as well as the retention of this state. Further, this effect is independent
of alterations in cell growth and may involve interactions between E2F4 and the neuronal differentiation
program itself. E2F4 may be an important participant in the terminal differentiation of neuroblasts.
While cell differentiation and growth arrest are distinct pro-
cesses that can occur independently, they are generally inti-
mately linked, with cell cycle exit being a prerequisite for
terminal differentiation. For example, proliferating neuroblasts
already exhibit several neuronal features, but the onset of
terminal differentiation does not occur until the final cell divi-
sion (14, 45). Clearly, mechanisms operating at the interface
between the growth arrest and differentiation programs play
critical roles in establishing the differentiated states of neurons
and other cell types. Such mechanisms are also likely to be
important in maintaining the irreversibility of terminal differ-
entiation, and their disruption plays an important role in cell
immortalization and tumorigenesis. Several cell cycle-associ-
ated proteins have been directly implicated in the terminal
differentiation process, including the retinoblastoma protein
(pRb) and the cyclin-dependent kinase inhibitor p21/WAF1
(17, 19). Importantly, recent studies have shown that these
proteins have dual regulatory effects on cell cycle progression
and cell differentiation that occur by distinct mechanisms (12,
47).
Members of the E2F family of transcriptional regulators
have a central role in the cell cycle-dependent expression of
genes required for DNA synthesis and S-phase entry, and
functional studies have provided direct evidence for their in-
volvement in the G1/S transition as well as apoptosis (for a
review, see references 22 and 40). Six E2F family members
have been characterized (E2F1 through E2F6), and they ex-
hibit various degrees of structural relatedness (6, 13, 22, 51).
E2Fs exist as heteromeric complexes consisting of an E2F and
a DP family member (the so-called “free” E2F) and, with the
exception of E2F6, also associate with a retinoblastoma (Rb)
family member under specific conditions. Dimerization with a
DP family member is necessary for optimal E2F transcriptional
activity, while complex formation with Rb family members
converts E2Fs into repressors of E2F-regulated genes. The
ectopic expression of E2F1, E2F2, or E2F3 is sufficient to
induce S-phase entry, while E2F4 or E2F5 by itself cannot (33).
This difference apparently reflects the fact that nuclear import
of E2F4 or E2F5 is cell cycle dependent (32, 35, 54).
While E2Fs are clearly important for cell cycle progression,
little is currently known about their potential functions during
cell differentiation. Differential changes in the expression or
activities of E2Fs following cell cycle exit and differentiation
have been demonstrated for several cell types, with E2F4 often
being the predominant species (42, 48, 53, 56). In certain
differentiated tissues, E2F5 appears to be selectively induced
(11). These observations suggest that, in addition to contrib-
uting to cell proliferation, E2F4 and E2F5 may be important
transcriptional regulators of growth arrest and/or differentia-
tion. However, the direct demonstration of the ability of these
transcriptional regulators to promote cell differentiation has
been lacking. In the present study, we show that E2F4 en-
hances both the initiation and maintenance of nerve growth
factor (NGF)-induced differentiation of PC12 cells into sym-
pathetic-like neurons and that these effects do not involve
changes in the regulation of cell growth. We also demonstrate
that inhibition of E2F4 protein levels interferes with the dif-
ferentiation process.
* Corresponding author. Mailing address: Department of Cellular
and Molecular Physiology, University of Massachusetts Medical
School, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508)
856-6274. Fax: (508) 856-5997. E-mail: daniel.kilpatrick@ummed.edu.
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MATERIALS AND METHODS
Cell cultures. PC12 cells were grown on collagen-coated plates in Dulbecco’s
modified Eagle medium (DMEM) with or without 10% horse serum–5% fetal
bovine serum and incubated at 37°C in 10% CO2. To induce neuronal differen-
tiation, cells were treated with 50 ng of NGF (Harlan Bioproducts) per ml for
various times. In washing experiments, NGF-treated cells were rinsed three times
with DMEM with or without serum and cultured for up to four additional days.
Plasmids and stable transfections. The plasmid pUHD15-1neo, containing
the tetracycline resistance repressor (tTA) fused in frame with the activation
domain of virion protein 16 of the herpes simplex virus, and the expression vector
pTETHAE2F4, containing the human E2F4 sequence inserted into pUHD10-3,
have been described (33). PC12 cells were transfected with equimolar amounts
of pTETHAE2F4 and pUHD15-1neo with Lipofectamine (GIBCO/BRL). Cells
were allowed to recover for 72 h prior to selection with G418 (200 mg/ml) and
tetracycline (2 mg/ml). Multiple colonies of PC12 cell derivatives (E2F4-tet cells)
were isolated, and the E2F4 induction and differentiation responses of two of
these colonies were fully characterized. The colonies behaved very similarly to
each other and to the original population of pooled clones.
RNA isolation and analysis. Total RNA was isolated from PC12 cells and rat
cerebral cortex by the guanidinium isothiocyanate-CsCl method, and Northern
blot analyses were performed as previously described (27). The various probes
used for Northern analysis were generated by restriction digestion with the
following: (i) for E2F1, a StyI-XhoI fragment from pSp72-RBAP1 (26); (ii) for
E2F3, a BamHI-BamHI fragment from pCMV-E2F3 (38); (iii) for E2F5, an
XbaI-HincII fragment from pCMV-E2F5 (23); and (iv) for cyclin A, an EcoRI-
SphI fragment from pCycA (55). The amount of RNA in each lane was normal-
ized with a human GAPDH (glyceraldehyde-3-phosphate dehydrogenase) cDNA
probe generated by PstI digestion of pHcGAP (52).
Protein extracts and Western blotting. Whole-cell extracts from PC12 cells
and rat cortex and cerebellum were prepared as previously described (2). Briefly,
cells were homogenized in whole-cell extraction buffer containing 20 mM
HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA, 10 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, 25% glycerol, 2 mg of pepstatin A per ml, 5 mg of
leupeptin per ml, 5 mg of ubenimex (Bestatin) per ml, and 5 mg of aprotinin per
ml and centrifuged for 10 min at 15,000 3 g. Supernatants were used for analysis.
Extracts were separated on sodium dodecyl sulfate (SDS)–10% polyacrylamide
gels, blotted onto polyvinylidene difluoride membranes, and reacted with rabbit
antibodies against E2F1, E2F4, E2F5, pRb, p107, p130, cyclin A, Sp1 (Santa
Cruz Biotech), and b-tubulin type III (Sigma). Incubations were carried out in
Tris-buffered saline containing 0.1% Tween 20 and 10% nonfat dry milk for 1 h
at room temperature. Protein bands were visualized by enhanced chemilumines-
cence (kit from DuPont/NEN, Boston, Mass.).
Cellular analyses. The extent of neurite outgrowth in E2F4-tet PC12 cell
derivatives was determined by the ratio of neurite length to cell body diameter
(9) (at least 300 to 400 cells were counted for each data point). The number of
viable cells was determined by cell counting by trypan blue exclusion. The rate of
DNA synthesis in E2F4-tet cells was determined by labelling 0.5 3 106 cells for
2 h with 1 mCi of [3H]thymidine. Washed cells were extracted at various times
with 2 N NaOH. Significance was examined by a one-way analysis of variance,
followed by Bonferroni multiple-comparison testing.
Isolation of nuclear and cytoplasmic fractions. For nuclear and cytoplasmic
extracts, cells were homogenized in 10 mM HEPES (pH 7.2) containing 150 mM
NaCl, 1.5 mM MgCl2, and protease inhibitors. Complete cellular disruption was
verified by trypan blue exclusion, and nuclear and cytoplasmic fractions were
generated by centrifugation at 800 3 g for 10 min. The nuclear pellet was washed
once with hypotonic buffer and then lysed with radioimmunoprecipitation assay
(RIPA) buffer (50 mM Tris-HCl [pH 8.1], 150 mM NaCl, 0.2% SDS, 1% sodium
deoxycholate, 1% Nonidet P-40, 5 mM EDTA).
Immunoprecipitations. Immunoprecipitations were performed on 200 mg of
whole-cell extracts in a final volume of 0.2 ml at 4°C for 1 h with 10 mg of p130
antibody (sc-317; Santa Cruz Biotech). Protein A/G Plus agarose (Santa Cruz
Biotech) was then added, and incubations were continued for an additional 16 h
at 4°C. Pellets were collected by centrifugation, washed four times with whole-
cell extraction buffer, and dissolved in electrophoresis sample buffer. Immuno-
precipitates were resolved on SDS–10% polyacrylamide gels, transferred to poly-
vinylidene difluoride membranes, and probed with E2F4 antiserum (sc-866;
Santa Cruz Biotech).
Antisense ODN treatment. Synthetic phosphorothioate oligodeoxynucleotides
(ODNs) were obtained from Oligos Etc. (Redding Center, Conn.). E2F4 anti-
sense ODNs were based on conserved mouse and human E2F4 sequences (3, 46)
and were as follows: AS1, 59-GCCTCCGCCATCGC-39 (residues 114 to 23 in
mouse E2F4 cDNA); AS2, 59-CCTGTGGCCCGGCCTCCG-39 (residues 122 to
15); and AS3, 59-TCGTGCCGGCTTGGAGTC-39 (residues 156 to 189). Con-
trol ODNs contained either the sense sequences complementary to AS1 and AS3
(S1 and S3) or the unrelated sequences 59-AGCCTCCGCCAGCAAGGCTG
C-39 (CS1) and 59-GTTTTGAGCAGCCATGGTGGA-39 (CS2). Treatment of
PC12 cells with ODNs (5 mM) was performed with or without NGF in the
presence of Transfast reagent (Promega, Madison, Wis.) as recommended by the
manufacturer. Fresh ODNs were added every 48 h for up to 6 days during NGF
treatment.
RESULTS
Regulation of E2F and Rb family members during neuronal
differentiation of PC12 cells. We utilized the PC12 cell model
to explore the role of E2Fs during neuronal differentiation.
These pheochromocytoma cells undergo growth arrest and
differentiation into postmitotic sympathetic-like neurons in the
presence of NGF and faithfully reproduce many important
features of sympathetic differentiation, including neurite out-
growth, regulation of cell cycle-associated genes, and NGF-
dependent survival (7, 37, 49, 59). Exposure of PC12 cells to 50
ng of NGF per ml for 8 days in the absence of serum or for 14
days in the presence of serum markedly downregulated the
levels of protein and/or mRNA for E2F1, E2F3, and E2F5
(Fig. 1). In contrast, E2F4 protein levels were markedly in-
creased in differentiated PC12 neurons (Fig. 1B). The increase
in E2F4 protein levels was even greater in neuronal derivatives
generated in the absence of serum, due to the upregulation of
E2F4 by serum removal alone (Fig. 1B), while the expression
of E2F5 protein and mRNA was inhibited under serum-free
conditions (Fig. 1). Thus, E2F4 protein levels increase mark-
edly following PC12 cell differentiation, while the levels of
other E2F proteins are greatly diminished or extremely low.
Analysis of Rb family members revealed that pRb and p107
proteins also were suppressed in neuronal derivatives, while
p130 was unchanged (Fig. 1B). We also examined the regula-
tion of cyclin A and cdk2, both of which are important for cell
cycle regulation and one of which (cyclin A) is regulated by
E2Fs in PC12 cells (22). In both cases, expression was mark-
edly suppressed following NGF-induced differentiation (Fig.
1).
E2F4 binds p130 and localizes to the nucleus following PC12
cell differentiation. E2F4 interactions with Rb family proteins
have a major impact on E2F4 function, including its conversion
from a trans-activator into a repressor of E2F-regulated cell
cycle genes (22, 39). In differentiated and growth-arrested
cells, E2F4 is often associated with the Rb family member p130
(8, 42, 53, 57), and the fact that p130 was unchanged by the
NGF-induced differentiation of PC12 cells, while pRb and
p107 were downregulated, suggests that E2F4-p130 complexes
may exist in these neuronal derivatives. p130-containing com-
plexes were immunoprecipitated and examined for the pres-
ence of E2F4. E2F4 protein was not detectable in p130 immu-
noprecipitates derived from proliferating PC12 cells but was
clearly evident in complexes from cells treated with NGF (Fig.
2A). The number of E2F4-p130 complexes was higher in PC12
cells treated with NGF in the absence of serum than in cells
treated in the presence of serum, which was consistent with the
increased concentrations of total E2F4 protein in these cells.
Also, E2F4 was readily detected in p130 immunoprecipitates
derived from PC12 cells cultured in serum-free medium alone.
The negative control protein Sp1 was undetectable on immu-
noblots of the same p130 precipitates (data not shown). Thus,
E2F4 associates with p130 in PC12 cells following growth ar-
rest and neuronal differentiation.
An additional effect of the interaction of E2F4 with Rb
family proteins is increased nuclear localization and, therefore,
enhanced transcriptional regulation (32, 35, 54). This was ex-
amined by the subcellular fractionation of PC12 cells with the
transcription factor Sp1 as a marker for the nuclear fraction
(25). Expression of Sp1 in PC12 cells is unaffected by NGF
treatment (58). The ratio of E2F4 within the nuclear and
cytosolic fractions increased considerably following NGF treat-
ment for 8 days (Fig. 2B). This was particularly evident in cells
which differentiated in serum-free medium (the presence of
significant amounts of cytosolic E2F4 in cells which differen-
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tiated in the presence of serum likely reflects the fact that
differentiation proceeds more slowly under these conditions
[15] and is incomplete after 8 days of NGF treatment). The
majority of E2F4 in growth-arrested, serum-deprived PC12
cells was also associated with the nuclear fraction (Fig. 2B).
These findings indicate that E2F4 is mainly or exclusively lo-
calized in the nucleus following neuronal differentiation.
Development of PC12 cell derivatives expressing E2F4 un-
der the control of a tetracycline-regulated promoter. The
above results suggested that E2F4 has a primary role in neu-
ronal differentiation relative to other E2Fs. To directly inves-
tigate this, we developed PC12 cell derivatives stably trans-
fected with a tetracycline-regulated expression plasmid for this
factor, together with a constitutively active vector encoding the
tetracycline transactivator tTA. With this system, E2F4 expres-
sion is repressed in the presence of tetracycline and induced
following its removal. Multiple cell lines (E2F4-tet cells) were
generated and examined for the expression of E2F4 in the
presence and absence of tetracycline (Fig. 3A). No E2F4 pro-
tein was detected in noninduced, proliferating E2F4-tet cells,
indicating tight regulation of the expression vector by tetracy-
cline. In contrast, E2F4 was readily detected following tetra-
cycline removal. The levels of induced E2F4 protein were, in
fact, similar to those obtained following growth arrest and
differentiation of uninduced PC12 cells (Fig. 3A) and thus
were quite physiological. Under serum-free, growth-arrested
conditions in which endogenous E2F4 is upregulated, the re-
moval of tetracycline resulted in a further, apparently additive
increase in E2F4 levels. Similarly, tetracycline removal resulted
in a marked increase in E2F4 levels in cells treated with NGF
for 6 days in either the presence or absence of serum (Fig. 3A).
Thus, E2F4-tet cells exhibit substantial induction of E2F4 ex-
pression in proliferating, quiescent, and differentiated PC12
cells.
Effects of E2F4 induction on neuronal differentiation of
PC12 cells. To examine its effects on PC12 cell differentiation,
E2F4 was induced prior to the initiation of NGF treatment.
Control studies verified that tetracycline treatment had no
FIG. 1. Expression of E2F and Rb family members following NGF treatment of PC12 cells. (A) Northern analysis. GAPDH mRNA was used to monitor the relative
loading of total RNA (30 mg/lane). (B) Western analysis (30 mg of protein/lane). Cells were cultured in the presence or absence of serum and with or without NGF
for 6, 8, or 14 days, as indicated. Cells were treated with NGF for a longer time in the presence of serum, since the differentiation response is slower under these
conditions (15).
FIG. 2. E2F4 associates with p130 and localizes to the nucleus in neuronal
derivatives of PC12 cells. Wild-type cells were cultured with or without serum
and with or without NGF for 8 days. (A) p130 complexes were immunoprecipi-
tated (IP) with p130 antibodies from 200 mg of whole-cell extracts and subjected
to Western blot (immunoblot [IB]) analysis with E2F4 antiserum. (B) Western
blot analysis of nuclear (n) and cytosolic (c) protein fractions from wild-type
PC12 cells. A total of 50 mg of protein was loaded per lane. Transcription factor
Sp1 was used as a nuclear marker.
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effect on either the differentiation of wild-type PC12 cells or
their response to NGF withdrawal (data not shown). E2F4-tet
cells were treated with 50 ng of NGF per ml for up to 8 days in
serum-containing medium in the presence and absence of tet-
racycline. Major differences in the rate of morphological dif-
ferentiation that were most dramatic after 2 to 3 days of NGF
treatment were observed (Fig. 3B). E2F4-induced cells had a
much more mature neuronal appearance at this time, including
a flattened morphology and the prevalence of markedly longer
neurites. In contrast, E2F4 induction did not alter the mor-
phology of proliferating PC12 cells (data not shown).
The effects of E2F4 preinduction on PC12 cell differentia-
tion were quantified by determining the ratio of neurite length
to cell body diameter. Cells were classified according to this
ratio (,1, 1 to 2, and .2 cell body diameters), with more-
differentiated cells possessing higher values. On day 2 of NGF
treatment, .70% of E2F4-induced cells were significantly dif-
ferentiated (bearing neurites 1 cell diameter or greater in
length), while only 25% of uninduced cells possessed neurite
lengths of 1 to 2 cell diameters; none had neurites longer than
2 cell diameters (Fig. 3C). By day 8 of NGF treatment, 100%
of uninduced cells exhibited a differentiated phenotype, and
thus E2F4 enhancement of differentiation could no longer be
detected.
The neuronal marker b-tubulin type III (18) was used to
monitor the effects of E2F4 preinduction on the biochemical
differentiation of PC12 cells by NGF. b-Tubulin protein levels
increased following the NGF treatment of E2F4-tet cells, and
the rate of this increase was substantially higher when E2F4
was preinduced (Fig. 3D) on days 2 and 4 of NGF treatment.
Thus, the ectopic expression of E2F4 markedly enhances the
onset of neuronal differentiation in PC12 cells.
E2F4 and maintenance of the neuronal phenotype. A char-
acteristic feature of NGF-treated PC12 cells is their ability to
FIG. 3. E2F4 induction accelerates the differentiation response of PC12
cells. (A) Western analysis of E2F4 protein expression in E2F4-tet cells. Cells
were cultured for 6 days in the presence or absence of NGF and tetracycline (tet)
in serum-free or serum-containing medium. Ectopic E2F4 expression was in-
duced following the removal of tetracycline. (B) Effect of E2F4 induction on the
morphological differentiation of PC12 cells by NGF. Phase-contrast microscopy
of E2F4-tet PC12 cells cultured with or without NGF for 4 days in the presence
of serum was done. Tetracycline was either present in (E2F4 off) or absent from
(E2F4 on) the culture medium. (C) Quantitation of neurite outgrowth in E2F4-
tet cells following NGF treatment. The extent of outgrowth was determined by
the ratio of neurite length to cell body diameter (9). Results are presented as the
percentage of total cells counted and represent means 1 standard errors of three
to four independent experiments. The x axis shows cell body diameters. Cells
were cultured in either the presence (black bars, not induced) or absence (shad-
ed bars, induced) of tetracycline and were treated with NGF in serum-containing
DMEM for 2 to 8 days. One-way analysis of variance was used for statistical
analysis. p, P , 0.05; pp, P , 0.01; ppp, P , 0.001. (D) Western analysis of
b-tubulin expression in E2F4-tet cells. Cell extracts were analyzed at various days
following NGF treatment in the presence of serum, with and without tetracycline
(tet) in the culture medium. The same membrane was reprobed with antibodies
against transcription factor Sp1.
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FIG. 4. Effect of E2F4 induction on the response of differentiated PC12 cells
to NGF withdrawal. (A) Western analysis of E2F protein expression following
removal of NGF from wild-type PC12 cells. PC12 cells were treated with NGF in
serum-containing medium for 14 days and then washed (w) and cultured with
serum for up to 4 days. (B) Phase-contrast microscopy of E2F4-tet cells treated
with NGF in the presence of serum for 8 days, then washed three times to
remove NGF, and incubated in either the presence [wash (1)] or absence [wash
(2)] of serum for 2 days, as indicated. Tetracycline was either present in (E2F4
off) or absent from (E2F4 on) the culture medium. (C) Neurite outgrowth in
E2F4-tet derivatives following the washing of NGF-treated cells. Cells were
treated with NGF in serum-containing DMEM for 8 days and then were washed
in medium with or without serum for 2 or 4 days. Data were analyzed as for Fig.
3. (D) Western analysis of b-tubulin expression. E2F4-tet cells were treated with
NGF in serum-containing medium for 8 days with or without tetracycline (tet)
and then either harvested (8 days) or washed (w) and cultured in the absence of
NGF for 2 or 4 days. The same membrane was probed for Sp1 protein as an
internal control.
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undergo reversible differentiation and renewed proliferation
upon NGF removal in the presence of serum (16). Western
analysis demonstrated that E2F4 protein decreased to unde-
tectable levels after the removal of NGF from differentiated
PC12 cells and further culturing for 4 days in the presence of
serum, while the expression of both E2F1 and E2F5 increased
(Fig. 4A). We therefore examined whether ectopic expression
of E2F4 would promote retention of the differentiated state in
neuronal derivatives undergoing dedifferentiation. E2F4-tet
cells were differentiated with NGF in the presence of serum for
8 days with and without tetracycline and then washed and
cultured in serum-containing medium alone. Cells in which
E2F4 was induced (without tetracycline) lost neurites at a
considerably lower rate than uninduced E2F4-tet cells after
NGF removal (Fig. 4B). The number of cells possessing neu-
rites of 1 to 2 cell body diameters or more was 4.3-fold higher
on the fourth day of washing (Fig. 4C). Further, the expression
of b-tubulin type III decreased at a lower rate following NGF
removal from induced E2F4-tet cells (Fig. 4D).
Neuronal derivatives of PC12 cells lose their neurites and
subsequently die via an apoptotic mechanism if cultured in
serum-free medium without NGF (37). When differentiated
E2F4-tet cells were washed and cultured in medium lacking
both serum and NGF, the induced cells retained their differ-
entiated morphology to a much greater degree than did the
uninduced cells (Fig. 4B). This effect was particularly dramatic
on the fourth day following NGF removal, when .90% of
induced E2F4-tet cells contained neurites of intermediate
length or greater while no uninduced cells had this phenotype
(Fig. 4C). Thus, in addition to accelerating the onset of neu-
ronal differentiation, E2F4 also promotes the maintenance of
the differentiated state of PC12 cell-derived neurons.
Growth regulation in E2F4-induced PC12 cells during dif-
ferentiation. In contrast to its impact on cell differentiation,
E2F4 induction had no significant effect on DNA synthesis or
cell number in PC12 cells undergoing growth arrest and dif-
ferentiation in response to NGF (Fig. 5A and data not shown).
Similarly, these parameters were unaltered during the dedif-
ferentiation and growth renewal of PC12 cell-derived neurons
following NGF withdrawal in the presence of serum (Fig. 5B
and data not shown). The ectopic expression of E2F4 also had
no major effect on the survival rate of NGF-deprived neuronal
derivatives in serum-free medium, although there was a trend
toward decreased cell loss (data not shown). Thus, E2F4 en-
hancement of both the onset and retention of PC12 cell dif-
ferentiation is independent of any marked alteration of growth
arrest or cell proliferation.
Role of endogenous E2F4 in neuronal differentiation of
PC12 cells. To determine whether E2F4 was normally involved
in PC12 cell differentiation, antisense ODNs (AS1 to AS3)
were designed for sequences spanning or adjacent to the trans-
lation initiation region which are unrelated to sequences within
the other E2Fs. All three antisense ODNs markedly reduced
the expression of E2F4 in NGF-treated PC12 cells, with AS1
and AS2 being more effective than AS3 (Fig. 6A). When tested
for their effects on NGF-dependent neurite outgrowth from
PC12 cells, the antisense ODNs inhibited this process with the
same order of efficacy, while sense or unrelated control ODNs
had negligible effects on both E2F4 protein levels and neurite
outgrowth (Fig. 6 and data not shown). Thus, E2F4 has an
important regulatory role in the NGF-induced differentiation
of PC12 cells.
Regulation of E2F4 expression during development of the
rat central nervous system. We also examined whether the
pattern of E2F expression in developing neural tissue was
similar to that observed in differentiating PC12 cells. During
neurogenesis of the rat cerebral cortex, proliferating neuro-
blasts within the subventricular zone become postmitotic and
begin their migration to upper cortical layers in a wave occur-
ring in the late embryonic and early postnatal period (36). An
analysis of the rat cerebral cortex revealed that the expression
of both E2F1 and E2F5 was downregulated as cortical neurons
became postmitotic between E18 and P1 to P3 (Fig. 7A and B).
Cyclin A expression was similarly downregulated in the cere-
bral cortex, as previously reported (21). In contrast, E2F4
protein was substantially upregulated during this period of
terminal growth arrest and neuronal differentiation (Fig. 7B).
Similar analyses were performed with developing rat cere-
bellum. During postnatal weeks 2 and 3, granule cell neuro-
blasts within the extragranular layer terminally exit the cell cycle
and migrate inward (1). Western analysis of rat cerebellar extracts
during this period revealed a gradual but large increase in E2F4
expression (Fig. 7C). In contrast, E2F5 protein was essentially
undetectable during this developmental period in the rat cer-
ebellum (data not shown). Thus, E2F4 is upregulated in the rat
central nervous system as neuroblasts become postmitotic and
differentiate, as occurs in PC12 cell-derived neurons.
DISCUSSION
E2FA facilitates the differentiation process. E2F4 is one of
a family of factors known to be critical for normal progression
FIG. 5. Induction of E2F4 does not alter DNA synthesis in NGF-treated
PC12 cells. (A) [3H]thymidine incorporation was determined during the differ-
entiation response to NGF. Cells were treated with NGF in serum-containing
medium for 2, 4, or 8 days in either the presence (black bars, uninduced) or
absence (shaded bars, induced) of tetracycline. (B) DNA synthesis was deter-
mined following washing of differentiated E2F4-tet cells. Cells were treated with
NGF in the presence of serum for 8 days and then washed and cultured with (1)
or without (2) serum in either the presence or absence of tetracycline, as for
panel A. Data are expressed as the means 6 standard errors of three to four
independent experiments.
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through the G1 and S phases of the cell cycle. The present
studies have demonstrated an additional activity for this factor,
specifically in the differentiated state. The expression of E2F4
increases markedly in neuronal derivatives of PC12 cells, and
its ectopic expression enhances both the initiation of neuronal
differentiation and its maintenance when examined under re-
versal conditions. Further, experiments with antisense ODNs
have shown that E2F4 is an important regulator of NGF-
induced differentiation. To our knowledge, this is the first
demonstration of a direct role for mammalian E2F factors in
promoting the differentiation of any cell lineage. Mutation
studies of the Drosophila melanogaster E2F gene have previ-
ously suggested a role for this factor in postmitotic cells (5),
and a nonproliferative function in secretion by epithelial cells
of the choroid plexus was recently demonstrated for mouse
E2F5 in gene knockout studies (31). The present findings sug-
gest that E2F4 may have therapeutic potential in inhibiting the
reversal of differentiation that often follows the treatment of
certain tumors with differentiating agents (20).
While important for the neuronal differentiation of PC12
cells, E2F4 induction by itself was not sufficient to initiate this
process. This is not surprising in light of the dual roles of E2F4
in cell cycle progression and differentiation. To promote dif-
ferentiation, E2F4 presumably must form complexes with fac-
tors which promote its nuclear localization and appropriately
regulate its transcriptional activity. That is, its nuclear entry
depends on its association with either a DP or Rb partner (32,
35, 54), and the nature of the facilitating partner(s) is an
important determinant of its transcriptional activity: e.g., DP
partners enhance transactivation, while Rb proteins convert
the E2F complex into a transrepressor. Association with p130
is, therefore, presumably important for the nuclear localization
and function of E2F4 during the neuronal differentiation of
PC12 cells. In contrast to the present results, the ectopic ex-
pression of E2F4 induces cell cycle reentry in quiescent muscle
cells when overexpressed with DP3D (43). This apparently
reflects limiting levels of Rb family members under the latter
conditions, since E2F4 complexes formed with p130 and p107
are associated with growth arrest in these cells. Thus, whether
E2F4 promotes cell proliferation or differentiation is deter-
mined to a great degree by the nature of its associated part-
ners.
E2Fs and terminal differentiation of neuroblasts. The ter-
minal differentiation of postmitotic neurons is not initiated
until permanent exit from the cell cycle (36), and this event
represents a critical juncture in nervous system development.
Loss of either pRb or p130 leads to the uncontrolled prolifer-
ation and subsequent apoptosis of central and peripheral neu-
roblasts, as well as the incomplete differentiation of surviving
cells (28, 29). Studies employing adenovirus E1A proteins have
also implicated Rb family members in the neuronal differen-
tiation of PC12 cells by NGF (4). A central mechanism by
which Rb members presumably regulate the arrest and differ-
entiation of neurons is via interactions with E2Fs. Consistent
with this, the presence of free E2F complexes (i.e., lacking Rb
family members) as well as the increased expression of an E2F
target, the cyclin E gene, is associated with the altered prolif-
FIG. 6. Analyses with antisense ODNs. (A) Analysis of E2F4 and Sp1 pro-
teins in extracts following ODN treatment of PC12 cells. PC12 cells were treated
with NGF for 6 days in the presence or absence of ODNs. (B) Neurite outgrowth
in PC12 cells following antisense-ODN treatment for 5 days. The percentage of
total cells bearing neurites more than 2 cell body diameters in length were
determined. Results are expressed relative to those for cells treated with NGF in
the absence of ODNs and are the averages of five independent experiments. N,
cells treated with NGF without ODN; C1, control unrelated ODN.
FIG. 7. Developmental regulation of E2F gene expression in rat central nervous system. Rat cortex (A and B) and cerebellum (C) were examined. (A) Northern
analysis was performed as for Fig. 1. (B and C) Western analyses. Thirty micrograms each of total RNA and protein extracts was loaded per lane.
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eration of central nervous system neurons in Rb-deficient mice
(34).
The present studies suggest that E2F4 is an important tran-
scriptional regulator of the terminal differentiation of neuro-
blasts. Expression of E2F4 protein markedly increases in the
rat cerebral cortex and cerebellum as neurons become postmi-
totic and is consistent with the pattern of E2F4 mRNA expres-
sion observed during neurogenesis in the mouse (10). It has
been found that E2F1, E2F2, and E2F5 mRNAs are down-
regulated while E2F4 transcripts are readily detected in post-
mitotic neurons of the mouse (10, 50). E2F4 is also upregu-
lated following the differentiation of human neuroblastoma
cells (44). The demonstration of E2F4-p130 complexes follow-
ing the neuronal differentiation of PC12 cells, together with the
required role for p130 in neuronal development (28), further
implicates E2F4 in this process.
Mechanisms of E2F4 action during differentiation. The spe-
cific mechanisms by which E2F4 enhances differentiation of
PC12 cell-derived neurons and possibly other cell types remain
to be determined. E2F complexes containing p130 predomi-
nate in the G0 state of many differentiated cells and tissues
(although complexes with other Rb family members are also
sometimes observed), and E2F4 is often the major E2F species
detected (8, 38, 42, 57). E2F-p130 complexes are thought to
function by repressing the expression of genes that are re-
quired for G1/S-phase transition and DNA synthesis (24, 30).
Thus, one mechanism by which E2F4 may promote neuronal
differentiation is by the repression of G1/S-associated genes,
which, in turn, would facilitate cell cycle exit (Fig. 8). The
downregulation of E2F target genes, i.e., the cyclin A, p107,
and pRb genes as well as the gene for E2F1 itself, in differen-
tiated PC12 cells and neurons, as described here and in other
studies (10, 21, 41), is consistent with this mechanism. How-
ever, E2F4 induction had no effect on the growth regulation of
PC12 cells by NGF, indicating that additional, cell cycle-inde-
pendent mechanisms are operative. In particular, these results
suggest that E2F4 may directly interact with the differentiation
program itself, either as complexes with p130 or in some other
form (Fig. 8). Both pRb and p21/WAF1 can influence cell
differentiation independent of their effects on the cell cycle
(12, 47), and E2F4 may also have dual yet distinct roles in
regulating cell growth and differentiation. The present study
defines a system in which these and other important aspects of
E2F4 function during cell differentiation can now be ad-
dressed.
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